Shi Zihai, Deputy Director of the National Medical Insurance Agency, went to Shanghai to conduct research and attend the opening ceremony of the eleventh batch of drug procurement activities.

On October 27, Shi Zihai, member of the Party Group of the National Healthcare Security Administration and Deputy Director, went to Shanghai to attend the opening ceremony of the eleventh batch of national centralized drug procurement and conducted on-site investigations of pharmaceutical innovation enterprises in Shanghai to listen to opinions and suggestions. Shi Zihai pointed out that it is necessary to implement the deployment requirements of the State Council on optimizing the measures for centralized procurement of drugs and consumables, and to carry out procurement work in a standardized, institutionalized, and normalized manner. It is important to carefully organize the opening ceremony of the centralized procurement, adhere to fairness, justice, and transparency, and ensure that the results of the procurement can withstand scrutiny. It is necessary to play the role of strategic purchasing in healthcare insurance, firmly support the development of pharmaceutical innovation, support true innovation and differentiation, and meet the diverse and multi-level medication needs of the people.